Clinical trials
Active, not recruiting Phase 2/3 trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
29 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 7 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 29 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 3 |
| Bristol-Myers Squibb | 2 |
| Janssen Research & Development, LLC | 2 |
| ALX Oncology Inc. | 1 |
| Agios Pharmaceuticals, Inc. | 1 |
| Australasian Gastro-Intestinal Trials Group | 1 |
| BioNTech SE | 1 |
| Biogen | 1 |
| Biohaven Therapeutics Ltd. | 1 |
| Camurus AB | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Squamous Cell Carcinoma of Head and Neck | 3 |
| Carcinoma, Non-Small-Cell Lung | 2 |
| Head and Neck Neoplasms | 2 |
| Melanoma | 2 |
| Recurrence | 2 |
| Stomach Neoplasms | 2 |
| Anemia, Sickle Cell | 1 |
| Ataxia | 1 |
| Blindness | 1 |
| Brain Neoplasms | 1 |
Trials
Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.